
6-Azauracil | CAS:461-89-2
6-Azauracil
- 名称:6-氮杂脲嘧啶; 1,2,4-三嗪-3,5-二酮 | 6-Azauracil
- CAS号:461-89-2
- 别名:3,5-Dihydroxy-1,2,4-triazine; 1,2,4-Triazine-3,5-dione
- 分子式:C3H3N3O2
- 分子量:113.07
- EINESC号:207-318-0
产品描述
物理化学性质
熔点 | 276-280 ºC |
---|
安全数据
危险品标志 | T |
---|---|
危险类别码 | R25;R36/37/38;R63 |
安全说明书 | S26;S36/37/39;S38;S45 |
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease.P Schadewaldt et al.Clinical chemistry, 45(10), 1734-1740 (1999-10-03)
Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease.P Schadewaldt et al.Journal of inherited metabolic disease, 22(6), 706-722 (1999-09-03)
Comparative utilization of the alpha-keto and D- and L-alpha-hydroxy analogs of leucine, isoleucine and valine by chicks and rats.K P Boebel et al.The Journal of nutrition, 112(10), 1929-1939 (1982-10-01)
Hydroxycarboxylic and oxocarboxylic acids in urine: products from branched-chain amino acid degradation and from ketogenesis.H M Liebich et al.Journal of chromatography, 309(2), 225-242 (1984-08-10)
Urinary D-4-hydroxyphenyllactate, D-phenyllactate and D-2-hydroxyisocaproate, abnormalities of bacterial origin.L J Spaapen et al.Journal of inherited metabolic disease, 10(4), 383-390 (1987-01-01)
2-Hydroxyisocaproic acid (HICA): a new potential topical antibacterial agent.M Sakko et al.International journal of antimicrobial agents, 39(6), 539-540 (2012-04-10)
Continuous enzymatically catalyzed production of L-leucine from the corresponding racemic hydroxy acid.B Bossow et al.Annals of the New York Academy of Sciences, 506, 325-336 (1987-01-01)
[The growth of rats in renal compensatory adaptation in feeding with a supplemented diet of hydroxy-analogs of essential amino acids].M Friedrich et al.Zeitschrift fur Urologie und Nephrologie, 82(2), 105-112 (1989-02-01)
Severe illness caused by the products of bacterial metabolism in a child with a short gut.E Haan et al.European journal of pediatrics, 144(1), 63-65 (1985-05-01)
Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease.Fernanda U Fontella et al.Metabolic brain disease, 17(1), 47-54 (2002-03-16)
Bioactivation mechanism of L-thiomorpholine-3-carboxylic acid.K D Webster et al.Archives of biochemistry and biophysics, 273(2), 562-571 (1989-09-01)
Reprogramming of the antimycin NRPS-PKS assembly lines inspired by gene evolution.Takayoshi Awakawa et al.Nature communications, 9(1), 3534-3534 (2018-09-01)
Chronic α-hydroxyisocaproic acid treatment improves muscle recovery after immobilization-induced atrophy.Charles H Lang et al.American journal of physiology. Endocrinology and metabolism, 305(3), E416-E428 (2013-06-13)
Studies of urinary organic acid profiles of a patient with dihydrolipoyl dehydrogenase deficiency.T Kuhara et al.Clinica chimica acta; international journal of clinical chemistry, 133(2), 133-140 (1983-09-30)
Rapid diagnosis of phenylketonuria and other aminoacidemias by quantitative analysis of amino acids in neonatal blood spots by gas chromatography-mass spectrometry.Chunhui Deng et al.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 775(1), 115-120 (2002-07-09)
NMR spectroscopic detection of chirality and enantiopurity in referenced systems without formation of diastereomers.Jan Labuta et al.Nature communications, 4, 2188-2188 (2013-07-19)
Alpha-keto acids are novel siderophores in the genera Proteus, Providencia, and Morganella and are produced by amino acid deaminases.H Drechsel et al.Journal of bacteriology, 175(9), 2727-2733 (1993-05-01)
Hydroxy acid metabolites of branched-chain amino acids in amniotic fluid.C Jakobs et al.Clinica chimica acta; international journal of clinical chemistry, 140(2), 157-166 (1984-07-16)
Effects of alfa-hydroxy-isocaproic acid on body composition, DOMS and performance in athletes.Antti A Mero et al.Journal of the International Society of Sports Nutrition, 7, 1-1 (2010-01-07)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!